Fractal Analytics reported a significant financial leap, with its Q4 profit after tax doubling to Rs 116 crore, fueled by an impressive 82% surge in its healthcare and life sciences division. The company’s overall revenue also saw a healthy 17% increase. This robust performance, coupled with a debt-free status post-IPO, positions Fractal for continued expansion.
This smallcap aerospace stock could soar 91%, predicts Nuvama
Nuvama has initiated coverage on Aequs with a ‘Buy’ rating and a target price of Rs 444, implying a 91% upside. The brokerage expects strong